Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Richeldi

Showing results (171-180 of 356) with videos related to

Pageof 36
Sort By:
European Respiratory Review : an Official Journal of the European Respiratory Society|December 17, 2025
High-flow nasal cannula in severe asthma exacerbations: current evidence and clinical perspectivesLorenzo Carriera, Simone Ielo, Roberto Barone, et al.
Thorax|September 28, 2016
Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volumeMartin Kolb, Luca Richeldi, Jürgen Behr, et al.
BMC Medicine|February 5, 2016
Treatment of idiopathic pulmonary fibrosis: a network meta-analysisBram Rochwerg, Binod Neupane, Yuan Zhang, et al.
American Journal of Respiratory and Critical Care Medicine|August 24, 2019
Which Biopsy to Diagnose Interstitial Lung Disease? A Call for Evidence and UnityLuca Richeldi, Vincent Cottin, Kevin K Brown, et al.
American Journal of Respiratory and Critical Care Medicine|August 15, 2024
Pioneering Research Driving Progress toward a Cure for Interstitial Lung Disease (ILD): Introduction to the <i>AJRCCM</i> Special Issue on ILD (Part 2)Anna J Podolanczuk, Toby M Maher, Wonder P Drake, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 2024
Watching an Evolution in Progress, Cutting-Edge Research Transforming Outcomes in Interstitial Lung Disease: Introduction to an <i>AJRCCM</i> Special IssueToby M Maher, Anna J Podolanczuk, Wonder P Drake, et al.
Respiratory Medicine|August 27, 2020
Restless legs syndrome: A new comorbidity in idiopathic pulmonary fibrosisFrancesco Varone, Ludovica Friello, Chiara Di Blasi, et al.
Chest|April 10, 2025
Effect of Admilparant, an Lysophosphatidic Acid Receptor 1 Antagonist, on Disease Progression in Pulmonary FibrosisMichael Kreuter, Toby M Maher, Wim A Wuyts, et al.
Physiological Measurement|January 17, 2025
Automated system for diagnosing pulmonary fibrosis using crackle analysis in recorded lung sounds based on iterative envelope mean fractal dimension filterRavi Pal, Anna Barney, Giacomo Sgalla, et al.
Respiratory Research|September 25, 2015
Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosisTamera Corte, Francesco Bonella, Bruno Crestani, et al.
Pageof 36

Showing results (171-180 of 356) with videos related to

Sort By:
Pageof 36
European Respiratory Review : an Official Journal of the European Respiratory Society|December 17, 2025
High-flow nasal cannula in severe asthma exacerbations: current evidence and clinical perspectivesLorenzo Carriera, Simone Ielo, Roberto Barone, et al.
Thorax|September 28, 2016
Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volumeMartin Kolb, Luca Richeldi, Jürgen Behr, et al.
BMC Medicine|February 5, 2016
Treatment of idiopathic pulmonary fibrosis: a network meta-analysisBram Rochwerg, Binod Neupane, Yuan Zhang, et al.
American Journal of Respiratory and Critical Care Medicine|August 24, 2019
Which Biopsy to Diagnose Interstitial Lung Disease? A Call for Evidence and UnityLuca Richeldi, Vincent Cottin, Kevin K Brown, et al.
American Journal of Respiratory and Critical Care Medicine|August 15, 2024
Pioneering Research Driving Progress toward a Cure for Interstitial Lung Disease (ILD): Introduction to the <i>AJRCCM</i> Special Issue on ILD (Part 2)Anna J Podolanczuk, Toby M Maher, Wonder P Drake, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 2024
Watching an Evolution in Progress, Cutting-Edge Research Transforming Outcomes in Interstitial Lung Disease: Introduction to an <i>AJRCCM</i> Special IssueToby M Maher, Anna J Podolanczuk, Wonder P Drake, et al.
Respiratory Medicine|August 27, 2020
Restless legs syndrome: A new comorbidity in idiopathic pulmonary fibrosisFrancesco Varone, Ludovica Friello, Chiara Di Blasi, et al.
Chest|April 10, 2025
Effect of Admilparant, an Lysophosphatidic Acid Receptor 1 Antagonist, on Disease Progression in Pulmonary FibrosisMichael Kreuter, Toby M Maher, Wim A Wuyts, et al.
Physiological Measurement|January 17, 2025
Automated system for diagnosing pulmonary fibrosis using crackle analysis in recorded lung sounds based on iterative envelope mean fractal dimension filterRavi Pal, Anna Barney, Giacomo Sgalla, et al.
Respiratory Research|September 25, 2015
Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosisTamera Corte, Francesco Bonella, Bruno Crestani, et al.
Pageof 36